T1	HMM 456 475	efficacy and safety
T2	HMM 827 888	number of patients with a modified Rankin score of 2 or less.
T3	HMM 917 1020	mortality, frequency of symptomatic intracranial haemorrhage (SIH), neurological and functional scores.
